Lifeward (LFWD) Net Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.82% |
| Dec 31, 2025 | -36.57% |
| Sep 30, 2025 | -22.94% |
| Jun 30, 2025 | 25.53% |
| Mar 31, 2025 | -38.20% |
| Dec 31, 2024 | 0.91% |
| Sep 30, 2024 | -3.75% |
| Jun 30, 2024 | -18.83% |
| Mar 31, 2024 | -62.70% |
| Dec 31, 2023 | -25.12% |
| Sep 30, 2023 | -45.89% |
| Jun 30, 2023 | -74.09% |
| Mar 31, 2023 | -0.85% |
| Dec 31, 2022 | -42.07% |
| Sep 30, 2022 | -7.53% |
| Jun 30, 2022 | -33.80% |
| Mar 31, 2022 | 2.64% |
| Dec 31, 2021 | -17.49% |
| Sep 30, 2021 | 59.15% |
| Jun 30, 2021 | 12.34% |
| Mar 31, 2021 | 64.22% |
| Dec 31, 2020 | 18.32% |
| Sep 30, 2020 | -7.73% |
| Jun 30, 2020 | -19.48% |
| Mar 31, 2020 | 15.66% |
| Dec 31, 2019 | -48.07% |
| Sep 30, 2019 | -15.59% |
| Jun 30, 2019 | 31.87% |
| Dec 31, 2018 | 28.81% |
| Sep 30, 2018 | -18.31% |